Analysis of disease activity categories in chronic spontaneous/idiopathic urticaria
Donald E. Stull(IQVIA (United States)), Clive Grattan(Guy's Hospital), Alexander Marsland(Salford Royal Hospital), Hao Tian(Central South University), Maria‐Magdalena Balp(Novartis (Switzerland)), Marcus Maurer(Humboldt-Universität zu Berlin), S Khalil(Novartis (Switzerland)), A. Gimenez Arnau(Universitat Autònoma de Barcelona), Doreen McBride(University College London)
Cited by 82
Related Papers
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.5k
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
|New England Journal of Medicine|2013|1.1k